<div id="readability-page-1"><div> By Katherine Hamilton <pre></pre> Senseonics shares slid after the company announced the pricing of its planned underwritten public offering. Shares fell 24% to $5.04 on Friday, at one point touching a 52-week low of $4.96. The stock has lost 9% of its value this year. The maker of implantable glucose trackers said late Thursday night it would price its underwritten public offering of 8 million shares at $5 apiece. It is also offering 8 million pre-funded warrants for just under $5 apiece. Senseonics expects proceeds to be $80 million. It has granted underwriters a 30-day option to buy up to an additional 2.4 million shares at the public offering price, less underwriting discounts and commissions. The offering is set to close May 4. <pre></pre> Write to Katherine Hamilton at katherine.hamilton@wsj.com <pre></pre> (END) Dow Jones Newswires May 01, 2026 14:37 ET (18:37 GMT)Copyright (c) 2026 Dow Jones &amp; Company, Inc.</div></div>

SENS

SBIO

LABU

Senseonics shares fell 24% to $5.04 following the announcement of its underwritten public offering priced at $5 per share. The company plans to offer 8 million shares and 8 million pre-funded warrants, expecting to raise $80 million. The stock has lost 9% of its value this year, hitting a 52-week low of $4.96. The offering is set to close on May 4, with underwriters granted a 30-day option to purchase an additional 2.4 million shares.

Senseonic Shares Slide on Underwritten Offering Price